Effective Support and Guidance
for Cancer Therapies
![]() |
maintrac® is an innovative blood test designed to detect circulating tumor cells — those responsible for the formation of metastases. Since cancer cells can change throughout the course of the disease, maintrac® enables precise monitoring of how the body responds to treatment.
By regularly measuring both the number and characteristics of these cells, physicians can make timely, informed decisions, adapting treatment strategies and selecting the most effective medications for each individual patient.
maintrac® supports the development of a personalised, targeted, and effective treatment plan, while continuously tracking therapeutic progress.
Innovative Laboratory Diagnostics for the Best Possible Outcomes in Cancer Treatment
maintrac® provides valuable diagnostic insights at every stage of treatment: from initial planning to long-term follow-up, offering clinicians and patients the ability to respond proactively and individually to disease progression or therapeutic resistance.
![]() |
maintrac® CELL COUNTING |
Therapy Monitoring and Direct Observation of Residual Tumor Burden During and After Treatment
|
![]() |
maintrac® DRUG SENSITIVITY TESTING |
Testing the Effectiveness of Drugs, Cytotoxic Agents, and Hyperthermia – Before and During Treatment
|
![]() |
maintrac® THERAPY-RELEVANT CHARACTERISTICS |
Testing for Indicators of Therapy Response or Non-Response
|
![]() |
stemtrac® TUMOR SPHERES |
Testing Tumor Spheres to Assess the Risk of Metastasis and Tumor Aggressiveness
|
Early Detection of Recurrence:
maintrac® can indicate a high likelihood
of cancer recurrence before clinical symptoms become apparent.
Therapy Monitoring:
maintrac® allows regular monitoring of circulating
tumor cell counts to show whether ongoing treatment is effective.
Individualised Therapy Adjustment:
maintrac® helps evaluate treatment
effectiveness, enabling early adaptation of therapies to optimise outcomes.
Non-Invasive Method:
maintrac® is based on a blood test, reducing the
need for invasive procedures to monitor the tumor.
CERTIFIED LABORATORY
ACCORDING TO DIN EN ISO 15189